BioRestorative Therapies, Inc. (BRTX): Total Liabilities

Annual figures by period end, from SEC filings.

$3.75M
As of 2024-12-31
+63.6%
3-year compound annual growth
-23.4%
5-year compound annual growth
-7.9%
10-year compound annual growth
$14.97M2010-12-31: $1.21M2011-12-31: $3.91M2012-12-31: $6.41M2013-12-31: $8.07M2014-12-31: $8.58M2015-12-31: $5.93M2016-12-31: $6.58M2017-12-31: $8.60M2018-12-31: $9.83M2019-12-31: $14.24M2020-12-31: $5.68M2021-12-31: $856.5K2022-03-31: $14.97M2022-06-30: $7.29M2022-09-30: $8.14M2022-12-31: $6.14M2023-03-31: $7.62M2023-06-30: $10.66M2023-09-30: $3.04M2023-12-31: $2.61M2024-12-31: $3.75M$3.75M
2010-12-31 Total Liabilities (USD) 2024-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2024-12-31$3.75M+43.8%2025-03-28, Balance as of period end
2023-12-31$2.61Mn/a2025-03-28, Balance as of period end
2023-09-30$3.04Mn/a2024-06-11, Balance as of period end
2023-06-30$10.66Mn/a2024-06-11, Balance as of period end
2023-03-31$7.62Mn/a2024-06-11, Balance as of period end
2022-12-31$6.14Mn/a2024-06-11, Balance as of period end
2022-09-30$8.14Mn/a2024-06-11, Balance as of period end
2022-06-30$7.29Mn/a2024-06-11, Balance as of period end
2022-03-31$14.97Mn/a2024-06-11, Balance as of period end
2021-12-31$856.5K-84.9%2023-03-27, Balance as of period end
2020-12-31$5.68M-60.1%2022-03-30, Balance as of period end
2019-12-31$14.24M+44.8%2021-04-30, Balance as of period end
2018-12-31$9.83M+14.4%2021-03-18, Balance as of period end
2017-12-31$8.60M+30.6%2019-03-29, Balance as of period end
2016-12-31$6.58M+11.1%2018-04-02, Balance as of period end
2015-12-31$5.93M-30.9%2017-03-22, Balance as of period end
2014-12-31$8.58M+6.3%2016-03-30, Balance as of period end
2013-12-31$8.07M+25.9%2015-03-31, Balance as of period end
2012-12-31$6.41M+64.0%2014-04-11, Balance as of period end
2011-12-31$3.91M+222.2%2013-04-02, Balance as of period end
2010-12-31$1.21Mn/a2012-04-16, Balance as of period end